Oral switch vs continued intravenous antibiotic therapy in patients with bacteraemia and sepsis: a systematic review and meta-analysis.

Clin Microbiol Infect

Department of Respiratory Medicine Children's Hospital of Chongqing Medical University, National Clinical Research Centre for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Key Laboratory of Children's Vital Organ Development and Diseases of Chongqing Health Commission, Chongqing, China. Electronic address:

Published: December 2024

Background: Bacteraemia and sepsis have traditionally required continued intravenous (IV) antibiotics.

Objectives: To evaluate if early transition to oral antibiotics is noninferior to continued IV antibiotic therapy in treating patients with bacteraemia and sepsis.

Data Sources: MEDLINE, Embase, Web of Science, the Cochrane library, and Wanfang databases from inception to July 13, 2024, along with clinical trial registries and Google.com.

Study Eligibility Criteria: Randomised controlled trials (RCTs) and cohort studies.

Participants: Patients with bacteraemia and sepsis.

Interventions: Early transition to oral antibiotics versus continued IV antibiotics. Early oral switch was defined as 5-9 days for uncomplicated Staphylococcus aureus bacteraemia, <4 weeks for complicated Staphylococcus aureus bacteraemia, 3-7 days for uncomplicated Streptococcus bacteraemia, and 3-5 days for uncomplicated Enterobacterales bacteraemia. Assessment of risk of bias: Cochrane risk of bias tool and Newcastle-Ottawa Scale.

Methods: of data synthesis: Random-effects models were used to pool the data. The primary outcome was treatment failure. The non-inferiority margin for treatment failure was 10%. The GRADE approach was used to rate the certainty of the evidence.

Results: In total, 38 studies (6 RCTs, 10 adjusted cohorts, and 22 unadjusted cohorts) involving 11,566 patients were included. A primary analysis of 6 RCTs and 10 adjusted cohorts comprised 7,102 patients. High-certainty evidence from six RCTs showed that early transition to oral antibiotics was noninferior to continued IV therapy for treatment failure (n=529; OR 0.89; 95% CI: 0.54 to 1.48). Low-certainty evidence from five adjusted cohorts also found no significant difference in treatment failure between the two groups (n=929; OR 0.60; 95% CI: 0.29 to 1.72). Moderate-certainty evidence showed that oral switch therapy significantly reduced hospital stay (n=2,041; mean difference: -5.19 days; 95% CI: -8.16 to -2.22).

Conclusions: Early transition to oral antibiotics was noninferior to continued IV antibiotic treatment for bacteraemia and sepsis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmi.2024.11.035DOI Listing

Publication Analysis

Top Keywords

patients bacteraemia
12
oral switch
8
continued intravenous
8
antibiotic therapy
8
bacteraemia sepsis
8
early transition
8
transition oral
8
oral antibiotics
8
bacteraemia
5
oral
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!